Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Medytox Solutions, Inc. | medytox_8k-ex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April 7, 2014
Medytox Solutions, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Nevada
(State or Other Jurisdiction of Incorporation)
| 000-54346 | 54-2156042 |
| (Commission File Number) | (I.R.S. Employer Identification No.) |
| 400 S. Australian Avenue, Suite 800, West Palm Beach, Florida | 33401 |
| (Address of Principal Executive Offices) | (Zip Code) |
| (561) 855-1626 |
| (Registrant’s Telephone Number, Including Area Code) |
| (Former Name or Former Address, if Changed Since Last Report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 – Other Events
Item 8.01. Other Events
On April 7, 2014, we issued a press release announcing our results of operations for the year ended December 31, 2013, as reported in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 31, 2014.
A copy of the press release is filed as Exhibit 99.1 to this Form 8-K.
Item 9.01. Exhibits
| Exhibit Number | Description |
| 99.1 | Press Release, dated April 7, 2014 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: April 7, 2014 | MEDYTOX SOLUTIONS, INC. |
| /s/ William G. Forhan | |
William G. Forhan, CEO and Chairman (principal executive officer) |
| 3 |
EXHIBIT INDEX
| Exhibit Number | Description |
| 99.1 | Press Release, dated April 7, 2014 |
| 4 |